Depression in multiple sclerosis: a review

Siegert, R. J.; Abernethy, D. A.
April 2005
Journal of Neurology, Neurosurgery & Psychiatry;Apr2005, Vol. 76 Issue 4, p469
Academic Journal
Several studies have reported high rates of depression in multiple sclerosis (MS) with a lifetime prevalence of ∼50% and an annual prevalence of 20% not uncommon. Concern about the potential of new drug treatments to exacerbate or precipitate depression in MS has led to increased interest in the relation between MS and depression. This review on MS and depression identifies the following key issues: How common is depression in people with MS? Is depression in MS associated with lesions in specific rejoins of the central nervous system? Is there an increased risk of suicide in MS? Is there a higher than expected incidence of anxiety disorders in MS? Are fatigue and depressed mood related in MS? Is there a relation between depression and cognitive impairment in MS? Which psychosocial variables affect the development of depression in MS? Does treatment with interferon increase the risk of depression? How effective are treatments for MS patients with depression? Each of these issues is briefly reviewed with critical commentary, and some priorities for future research are suggested.


Related Articles

  • Clinical implications of neuropathological findings in multiple sclerosis. Brück, Wolfgang // Journal of Neurology;Aug2005 Supplement 3, Vol. 252, piii10 

    Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. The pathological hallmarks of MS lesions in the brain and spinal cord are inflammation, demyelination, axon loss and gliosis. Recent studies revealed heterogeneity in the mechanisms leading to...

  • A Review of Pharmacologic and Therapeutic Interventions for Persons with Depression and Multiple Sclerosis. Feisthamel, Kevin P. // Annals of the American Psychotherapy Association;Spring2009, Vol. 12 Issue 1, p16 

    Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system that is very complex, extremely variable, and life-changing (Holland & Madonna, 2005). One of the most common psychiatric symptoms for individuals with MS is depression. However, little empirical literature...

  • Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Laman, J.D.; Maassen, C.B.M.; Schellekens, M.M.; Visser, L.; Kap, M.; de Jong, E.; van Puijenbroek, M.; van Stipdonk, M.J.B.; van Meurs, M.; Schwärzler, C.; Günthert, U. // Multiple Sclerosis (13524585);Jun98, Vol. 4 Issue 3, p147 

    Interactions between mononuclear cells are required for the formation of inflammatory infiltrates in the CNS and the activation of cellular effector functions provoking demyelination in MS. Membrane-expressed costimulatory molecules are crucial to such interactions. We therefore investigated...

  • Candidate autoantigens in multiple sclerosis. Schmidt, S. // Multiple Sclerosis (13524585);Jun99, Vol. 5 Issue 3, p147 

    Multiple sclerosis is an inflammatory demyelinating CNS disease of putatively autoimmune origin. Novel models of experimental autoimmune encephalomyelitis (EAE) have demonstrated that T cells specific for various myelin and even nonmyelin proteins are potentially encephalitogenic. The...

  • Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Pluchino, Stefano; Quattrini, Angelo; Brambilla, Elena; Gritti, Angela; Salani, Giuliana; Dina, Giorgia; Galli, Rossella; Del Carro, Ubaldo; Amadio, Stefano; Bergami, Alessandra; Furlan, Roberto; Comi, Giancarlo; Vescovi, Angelo L.; Martino, Gianvito // Nature;4/17/2003, Vol. 422 Issue 6933, p688 

    Widespread demyelination and axonal loss are the pathological hallmarks of multiple sclerosis. The multifocal nature of this chronic inflammatory disease of the central nervous system complicates cellular therapy and puts emphasis on both the donor cell origin and the route of cell...

  • A point mutation in PTPRC is associated with the development of multiple sclerosis. Jacobsen, Marc; Schweer, Dorothee; Ziegler, Andreas; Gaber, Rami; Schock, Sabine; Schwinzer, Reinhard; Wonigeit, Kurt; Lindert, Ralf-Björn; Kantarci, Orhun; Schaefer-Klein, Janet; Schipper, Hayo I.; Oertel, Wolfgang H.; Heidenreich, Fedor; Weinshenker, Brian G.; Sommer, Norbert; Hemmer, Bernhard // Nature Genetics;Dec2000, Vol. 26 Issue 4, p495 

    Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. It is widely accepted that a dysregulated immune response against brain resident antigens is central to its yet unknown pathogenesis[SUP1-4]. Although there is evidence that the development of MS has...

  • Paediatric UK demyelinating disease longitudinal study (PUDDLS).  // BMC Pediatrics;2011, Vol. 11 Issue 1, p68 

    The article presents information on the Paediatric UK Demyelinating Disease Longitudinal Study (PUDDLS), a study conducted in Great Britain on childhood central nervous system (CNS) inflammatory demyelinating diseases. CNS inflammatory demyelinating diseases may lead to physical and cognitive...

  • The Multifaceted Role of Interferon-γ in Central Nervous System Autoimmune Demyelination. Sanvito, Lara; Constantinescu, Cris S.; Gran, Bruno; 't Hart, Bert A. // Open Autoimmunity Journal;2010 Special Issue 3, p151 

    Extensive research has been devoted to the study of IFN-γ function in several autoimmune diseases. Previously considered the hallmark of Th1 differentiation and pro-inflammatory responses, it has soon become evident that this pivotal cytokine plays a much more complex role than initially...

  • The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. Wensheng Lin; Bailey, Samantha L.; Hanson Ho; Harding, Heather P.; Ron, David; Miller, Stephen D.; Popko, Brian // Journal of Clinical Investigation;Feb2007, Vol. 117 Issue 2, p448 

    In response to ER stress, the pancreatic endoplasmic reticulum kinase (PERK) coordinates an adaptive program known as the integrated stress response (ISR) by phosphorylating the α subunit of eukaryotic translation initiation factor 2 (eIF2α). IFN-γ, which activates the ER stress...


Read the Article


Sign out of this library

Other Topics